Current Cancer Therapy Reviews


Yangchao Chen
School of Biomedical Sciences
Faculty of Medicine
The Chinese University of Hong Kong
(Hong Kong)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 2 Issue: 3, August

Biological Basis of Novel Therapies for Myelodysplastic Syndrome

Volume:2   Issue: 3
Pp: 199-209
Eyal C. Attar and Karen K. Ballen
DOI: 10.2174/157339406777934708
Published on: 01 March, 2012

Current Treatment of Relapsed Ovarian Carcinoma

Volume:2   Issue: 3
Pp: 211-221
Aristotle Bamias, Alexandros Rodolakis and Meletios A. Dimopoulos
DOI: 10.2174/157339406777934726
Published on: 01 March, 2012

Lenalidomide: Cancer Therapy via Antiangiogenesis and Immunomodulation

Volume:2   Issue: 3
Pp: 223-229
Tanyifor M. Tohny, Jurgen Venitz, Alex Sparreboom and William D. Figg
DOI: 10.2174/157339406777934690
Published on: 01 March, 2012

A Role for Tumor Suppressor Protein p53 in the Fidelity of DNA Synthesis and Resistance Towards Nucleoside Analogs

Volume:2   Issue: 3
Pp: 231-241
Mary Bakhanashvili and Galia Rahav
DOI: 10.2174/157339406777934672
Published on: 01 March, 2012

Molecular Profiles of Sentinel and Non-Sentinel Lymph Nodes in Breast Cancer Progression and Prognosis

Volume:2   Issue: 3
Pp: 243-253
Gajanan V. Sherbet
DOI: 10.2174/157339406777934735
Published on: 01 March, 2012

Testicular Germ Cell Tumors: A Paradigm for the Successful Treatment of Solid Tumor Stem Cells

Volume:2   Issue: 3
Pp: 255-270
Caryl J. Giuliano, Sarah J. Freemantle and Michael J. Spinella
DOI: 10.2174/157339406777934681
Published on: 01 March, 2012

Cancer Therapy-Induced Residual Bone Marrow Injury: Mechanisms of Induction and Implication for Therapy

Volume:2   Issue: 3
Pp: 271-279
Yong Wang, Virginia Probin and Daohong Zhou
DOI: 10.2174/157339406777934717
Published on: 01 March, 2012